期刊文献+

肝移植术后感染的革兰氏阴性杆菌病原菌分布与耐药特征分析

The Analysis of the Infection of Gram-Negative Bacillus and the Characteristic of Their Drug-resistance After Liver transplantation
下载PDF
导出
摘要 目的研究肝移植术后感染的革兰氏阴性杆菌的病原菌及其药敏特征。方法采用KB法检测肝移植术后感染革兰氏阴性杆菌的药敏情况,双纸片确证法、三维试验检测肠杆菌的超广谱β内酰胺酶(ESBLs)、AmpC酶产酶情况。结果55例肝移植术后感染的病原菌中革兰氏阴性杆菌占47.6%,对4种及4种以上抗生素的耐药率均超过40%,阴沟肠杆菌与大肠杆菌的产ESBLs与产AmpC酶检出率分别为32.4%、36.8%和38.8%、10.5%。结论肝移植术后以革兰氏阴性杆菌感染为主,对抗生素具有高耐药性与多重耐药性特点,产ESBLs与产AmpC酶是主要革兰氏阴性杆菌产生耐药性的重要因素,应引起临床的高度重视。 Objective To study the infectious pathogens of Gram-Negative bacillus and their characteristic of antibiotic susceptibility after liver transplantation.methods The susceptibility of antimicrobial agents of the infectious Gram-Negative bacillus was detected by K-B method after liver transplantation.Extended-spectrum beta-lactamases(ESBLs)and Ampc β-lactamases were detected by disk diffusion method and three-dimensional tests respectively.Results Among 55 cases of the infection after liver transplantation the rate of Gram-Negative bacillus to the total pathogens was 47.6%. and the rate of drug-resistance to four or more antibiotic exceeded (40.0%),32.4%,while 36.8% produced ESBLs among Enterobacter cloacae and Escherichia coli,(33.8%) and 10.5% produced Ampc β-lactamases.Conclusion Gram-Negative bacillus may be the majority of the pathogens in the patients receiving liver transplantation, which have the chatacterestic of multiple drug-resistance.Producing ESBLs and Ampcβ-lactamases are the primary factor of antibiotic resistance of Gram-Negative bacillus.We should pay much attention to it during clinical process.
出处 《江西医学院学报》 2005年第3期17-19,共3页 Acta Academiae Medicinae Jiangxi
关键词 肝移植 感染 革兰氏阴性杆菌 耐药性 liver transplantation infection gram-negative bacillus drugtolerance
  • 相关文献

参考文献8

二级参考文献26

  • 1Das A.Cost-effectiveness of different strategies of cytomeg alovirus prophylaxis in orthotopic liver transplant recipients[J].Hepatology,2000,31(2): 311-317.
  • 2Torres A,Ewig S,Insausti J,et al.Etiology and microbial patterns of pulmonary infiltrates in patients wit h orthotopic liver transplantation[J].Chest,2000,117(2): 494-502.
  • 3Singh N,Chang FY,Gayowski T,et al.Fever in liver transpla nt recipients in the intensive care unit[J].Clin Transplant,1999,13(6): 504 -511.
  • 4Lohmann R,Langrehr JM,Klupp J,et al.Infect ious complications after orthotopic liver transplantation with different immunos uppressive induction regimens[J].Transplant Proc,2000,32: 537-538.
  • 5Malkan G,Cattral MS,Humar A,et al.Lamivudine for hepati tis B in liver transplantation: a single-center experience[J].Transplantatio n,2000,69(7): 1403-1407.
  • 6Keeffe EB.End-stage liv er disease and liver transplantation: role of lamivudine therapy in patients wit h chronic hepatitis B[J].J Med Virol,2000,61(3): 403-408.
  • 7Tseng CY,Liu PY,Wu WL,et al.Comparison of detection of extended-spectrum beta-lactamases by agar dilution method,E-test ESBL screen and double disk test[J].J Microbiol Immunol Infect 1998,31(2):90-94.
  • 8Sirot D.Extended-spectrum plasmid-mediated β-lactamases[J].J Antimicrob Chemot her,1996,(SupplA):19-34.
  • 9Liu PYF,Tung JC,Ke SC,et al.Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan[J].Clin Microbiol,1998,36:2759-2762.
  • 10Bush K,Jacoby GA,Medeiros AA.A functional classification scheme for β-lactamases and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995,39:1211-1233.

共引文献187

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部